Author

Fan Xu

Shanghai Jiao Tong UniversityORCID 0000-0003-4831-2604Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Fan Xu2 papers · Chongqing University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Ao Gu· 1 shared Fabao Chen· 1 shared Longxing CaoiD· 1 shared Maolan Li· 1 shared Ruobing Yu· 1 shared Weikang Yan· 1 shared Yali Liu· 1 shared Yang YuiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ao Gu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyJournal of Controlled ReleasePeer-reviewedSep 15, 2026

Nab-paclitaxel fused with the de novo designed receptor binder exhibits enhanced tumor targeting and therapeutic efficacy

Yuanying Qian, Weikang Yan, Fan Xu…·Yongning He

This paper modifies Nab-paclitaxel with receptor binders to improve tumor targeting and reduce toxicity, showing enhanced efficacy in cancer cells and xenograft models.

DOI 10.1016/j.jconrel.2026.115355

humanproteomics

𝕏 PostBluesky